Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Wampler

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reports|January 1, 1980
Phase II study of VM-26 in adult malignanciesE Spremulli, J J Schulz, V J Speckhart, et al.
Cancer Research|July 1, 1972
Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune responseA E Munson, J A Munson, W Regelson, et al.
Cancer Treatment Reports|August 1, 1977
On determining the levels of treatment to optimize the probability of a favorable responseW H Carter, G L Wampler, S L Crews, et al.
Biometrics|December 1, 1984
Confidence interval about the response at the stationary point of a response surface, with an application to preclinical cancer therapyW H Carter, V M Chinchilli, E D Campbell, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1992
Relationships between various uses of antineoplastic drug-interaction termsG L Wampler, W H Carter, E D Campbell, et al.
Journal of Biopharmaceutical Statistics|January 11, 1991
A method for determining schedule dependency in tissue cultureG L Wampler, W H Carter, E D Campbell, et al.
Cancer Research|August 1, 1982
Drug activity and therapeutic synergism in cancer treatmentW H Carter, G L Wampler, D M Stablein, et al.
Cancer|July 15, 1981
Intracerebral metastases in solid-tumor patients: natural history and results of treatmentS Zimm, G L Wampler, D Stablein, et al.
Cancer Treatment Reports|June 1, 1987
Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemiaG L Wampler, W H Carter, E D Campbell, et al.
Cancer Research|August 1, 1975
Antitumor activity of tetraacetylglucosamine mustardG L Wampler, S K Nassiri, Y Y Hsiao, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reports|January 1, 1980
Phase II study of VM-26 in adult malignanciesE Spremulli, J J Schulz, V J Speckhart, et al.
Cancer Research|July 1, 1972
Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune responseA E Munson, J A Munson, W Regelson, et al.
Cancer Treatment Reports|August 1, 1977
On determining the levels of treatment to optimize the probability of a favorable responseW H Carter, G L Wampler, S L Crews, et al.
Biometrics|December 1, 1984
Confidence interval about the response at the stationary point of a response surface, with an application to preclinical cancer therapyW H Carter, V M Chinchilli, E D Campbell, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1992
Relationships between various uses of antineoplastic drug-interaction termsG L Wampler, W H Carter, E D Campbell, et al.
Journal of Biopharmaceutical Statistics|January 11, 1991
A method for determining schedule dependency in tissue cultureG L Wampler, W H Carter, E D Campbell, et al.
Cancer Research|August 1, 1982
Drug activity and therapeutic synergism in cancer treatmentW H Carter, G L Wampler, D M Stablein, et al.
Cancer|July 15, 1981
Intracerebral metastases in solid-tumor patients: natural history and results of treatmentS Zimm, G L Wampler, D Stablein, et al.
Cancer Treatment Reports|June 1, 1987
Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemiaG L Wampler, W H Carter, E D Campbell, et al.
Cancer Research|August 1, 1975
Antitumor activity of tetraacetylglucosamine mustardG L Wampler, S K Nassiri, Y Y Hsiao, et al.
Pageof 6